| Product NDC: | 46987-330 |
| Proprietary Name: | Kadian |
| Non Proprietary Name: | morphine sulfate |
| Active Ingredient(s): | 150 mg/1 & nbsp; morphine sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 46987-330 |
| Labeler Name: | Actavis Kadian LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020616 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120507 |
| Package NDC: | 46987-330-11 |
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46987-330-11) |
| NDC Code | 46987-330-11 |
| Proprietary Name | Kadian |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46987-330-11) |
| Product NDC | 46987-330 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | morphine sulfate |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120507 |
| Marketing Category Name | NDA |
| Labeler Name | Actavis Kadian LLC |
| Substance Name | MORPHINE SULFATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |